Cutaneous manifestations of infective endocarditis

Authors

  • Victoria Catalina Mardon General Hospital of Acute Dr. Cosme Argerich, Autonomous City of Buenos Aires, Argentina
  • Bárbara Alonso General Hospital of Acute Dr. Cosme Argerich, Autonomous City of Buenos Aires, Argentina
  • María Inés Hernández General Hospital of Acute Dr. Cosme Argerich, Autonomous City of Buenos Aires, Argentina
  • Florencia Quadrana General Hospital of Acute Dr. Cosme Argerich, Autonomous City of Buenos Aires, Argentina
  • Alejandra Abeldaño General Hospital of Acute Dr. Cosme Argerich, Autonomous City of Buenos Aires, Argentina

Keywords:

infective endocarditis, Osler's nodes, Janeway lesions

Abstract

Infective endocarditis is a pathology with low incidence and high morbidity, so the early diagnosis and timely treatment are essential. Clinical presentation is varied; cutaneous manifestations include purpura, subungual hemorrhages, Osler’s nodes, and Janeway lesions. We report a case with skin´s lesions typical of IE caused by Staphylococcus aureus in a patient with systemic lupus erythematosus. The importance of the dermatological examination as a diagnostic element of this pathology is highlighted.

Author Biographies

Victoria Catalina Mardon, General Hospital of Acute Dr. Cosme Argerich, Autonomous City of Buenos Aires, Argentina

Second Year Concurrent. Dermatology Unit

Bárbara Alonso, General Hospital of Acute Dr. Cosme Argerich, Autonomous City of Buenos Aires, Argentina

Dermatologist Physician. Dermatology Unit

María Inés Hernández, General Hospital of Acute Dr. Cosme Argerich, Autonomous City of Buenos Aires, Argentina

Plant Doctor. Dermatology Unit

Florencia Quadrana, General Hospital of Acute Dr. Cosme Argerich, Autonomous City of Buenos Aires, Argentina

Chief of Residents. Dermatology Unit

Alejandra Abeldaño, General Hospital of Acute Dr. Cosme Argerich, Autonomous City of Buenos Aires, Argentina

Head of the Dermatology Unit. Dermatology Unit

References

I. Casabe JH. Endocarditis infecciosa: una enfermedad cambiante. Medicina 2008;68:164-174.

II. Casabe JH, Giunta G, Varini S, Brisani JL, et ál. Consenso de endocarditis infecciosa. Rev Argent Cardiol 2016;84:1-49.

III. Avellana PM, García Aurelio M, Swieszkowski S, Nacinovich F, et ál. Endocarditis infecciosa en la República Argentina. Resultados del estudio EIRA 3. Rev Argent Cardiol 2018;86:20-28.

IV. Servy A, Valeyrie-Allanore L, Alla, F, Lechiche C, et ál. Prognostic value of skin manifestations of infective endocarditis. JAMA Dermatol 2014;150:494–500.

V. Miller CS, Egan RM, Falace DA, Rayens MK, et ál. Prevalence of infective endocarditis in patients with systemic lupus erythematosus. J Am Dent Assoc 1999;130(3):387-392.

VI. Alpert JS, Krous HF, Dalen JE, O'Rourke RA, et ál. Pathogenesis of Osler's nodes. Ann InternMed 1976;85:471-473.

VII. Farrior JB, Silverman ME. A consideration of the differences between a Janeway's lesion and an Osler's node in infectious endocarditis. Chest1976;70:239-243.

VIII. Kerr A, Tan J. Biopsies of the Janeway lesion of infective endocarditis. J Cutan Pathol 1979;6:124-129.

IX. Yee J, McAllister K. The utility of Osler's nodes in the diagnosis of infective endocarditis. Chest1987;92:751-752.

X. Li JS, Sexton DJ, Mick N, Nettles R, et ál. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 2000;30:633-638.

Published

2019-09-20

Issue

Section

Clinical Cases